SS

Samuel Scofield

Investing in Life Sciences at Good Growth Capital

New York, New York

Investor
VC

Invests in

Stages:

Series A
Seed

  • Min Investment:

    $100,000.00

  • Max Investment:

    $2,000,000.00

  • Target Investment:

    $1,000,000.00

Skills

Microsoft Excel
Microsoft PowerPoint
Life Sciences
Strategy Consulting

Education

Lists including Samuel

AM
AR
AG
AH

Based in NYC

2599 people

AT
AS
AT
AH

All Series A Investors

14748 people

AM
AT
AS
AR

All Seed Investors

19691 people

Work Experience

GG
Good Growth Capital

2022

  • Senior Associate

    2023

  • Associate

    2022 - 2023

    Investing in early-stage life sciences companies Therapeutics: AdipoPharma, Tevard Biosciences Medical devices: Avisi Technologies, Coaptech, Pleural Dynamics, Relief Cardiovascular, Spiro Robotics, Venostent Diagnostics: AOA Dx Biomanufacturing: Aralez Bio Ag-Biotech: Robigo

AT
Avisi Technologies

2025

  • Board Observer

    2025

AB
Aralez Bio

2024

  • Board Observer

    2024

SR
Spiro Robotics

2023

  • Board Observer

    2023

AD
AOA Dx

2023

  • Board Observer

    2023

PD
Pleural Dynamics, Inc.

2023

  • Board Observer

    2023

VI
VenoStent, Inc.

2023

  • Board Observer

    2023

LC
L.E.K. Consulting

2022 - 2022

  • Associate

    2022 - 2022

PH
Prescient Healthcare Group

2020 - 2022

  • Senior Analyst

    2020 - 2022